Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Morano

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 10, 2012
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individualsM Maranghi, S Prudente, L D'Erasmo, et al.
The Pharmacogenomics Journal|July 12, 2017
Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locusS Prudente, R Di Paola, S Pezzilli, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|April 7, 2016
Tapentadol PR for Pain Syndromes in Real Life Patients with Hematological MalignancyGregorio A Brunetti, Giovanna Palumbo, Giacomo S Morano, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 10, 2012
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individualsM Maranghi, S Prudente, L D'Erasmo, et al.
The Pharmacogenomics Journal|July 12, 2017
Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locusS Prudente, R Di Paola, S Pezzilli, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|April 7, 2016
Tapentadol PR for Pain Syndromes in Real Life Patients with Hematological MalignancyGregorio A Brunetti, Giovanna Palumbo, Giacomo S Morano, et al.
Pageof 7